Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Substrate-Targeted Catheter Ablation to Treat Persistent Atrial Fibrillation

NCT02571218 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02571218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02571218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Substrate-Targeted Catheter Ablation to Treat Persistent Atrial Fibrillation
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2015
Completion date
February 28, 2017
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation